×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Institute of Chi... [4]
THE STATE KEY LA... [3]
Faculty of Healt... [2]
Authors
ZHANG QINGWEN [4]
WANG CHUNMING [1]
DI LIJUN [1]
KWOK HANG FAI [1]
WANG RUIBING [1]
WANG LI [1]
More...
Document Type
Journal article [3]
Book chapter [1]
Date Issued
2023 [2]
2022 [1]
2017 [1]
Language
英語English [3]
Source Publication
Biochemical Phar... [1]
EUROPEAN JOURNAL... [1]
PHARMACOLOGICAL ... [1]
Studies in Natur... [1]
Indexed By
SCIE [3]
BKCI-S [1]
IC [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-4 of 4
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Issue Date Ascending
Issue Date Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia
Journal article
Han, Han, Zhao, Chen, Liu, Mengchen, Zhu, Hongxuan, Meng, Fancheng, Zhang, Ying, Wang, Guibin, Wang, Li, Di, Lijun, Mingyuen Lee, Simon, Zhang, Qingwen, Cui, Guozhen. Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia[J]. Biochemical Pharmacology, 2023, 218, 115875.
Authors:
Han, Han
;
Zhao, Chen
;
Liu, Mengchen
;
Zhu, Hongxuan
;
Meng, Fancheng
; et al.
Favorite
|
TC[WOS]:
3
TC[Scopus]:
3
IF:
5.3
/
5.2
|
Submit date:2024/01/02
Chronic Myeloid Leukemia
Homoharringtonine
Mitochondrial Complex i
Oxidative Phosphorylation
Proteomics
T315i Mutation
Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application
Journal article
Qiushuang Wu, Pengchen Chen, Junnan Li, Ziqi Lin, Qingwen Zhang, Hang Fai Kwok. Inhibition of bladder cancer growth with homoharringtonine by inactivating integrin α5/β1-FAK/Src axis: A novel strategy for drug application[J]. PHARMACOLOGICAL RESEARCH, 2023, 188, 106654.
Authors:
Qiushuang Wu
;
Pengchen Chen
;
Junnan Li
;
Ziqi Lin
;
Qingwen Zhang
; et al.
Favorite
|
TC[WOS]:
18
TC[Scopus]:
18
IF:
9.1
/
9.0
|
Submit date:2023/02/22
Bladder Cancer
Extracellular Matrix
Metastasis
Homoharringtonine
Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia
Journal article
Yujian Yang, Qiuchun Yu, Lean Hu, Botao Dai, Ruxi Qi, Yu Chang, Qingwen Zhang, Zhang Zhang, Yingjun Li, Xumu Zhang. Enantioselective semisynthesis of novel cephalotaxine esters with potent antineoplastic activities against leukemia[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244, 114731.
Authors:
Yujian Yang
;
Qiuchun Yu
;
Lean Hu
;
Botao Dai
;
Ruxi Qi
; et al.
Favorite
|
TC[WOS]:
6
TC[Scopus]:
5
IF:
6.0
/
6.1
|
Submit date:2023/01/10
Cephalotaxine-type Alkaloid
Homoharringtonine
Leukemia
Antineoplastics
Enantioselective Semisynthesis
Asymmetric Hydrogenation
Chemistry, Bioactivity, and the Structure-Activity Relationship of Cephalotaxine-Type Alkaloids From Cephalotaxus sp.
Book chapter
出自: Studies in Natural Products Chemistry, Netherlands:Elsevier, 2017, 页码:339-373
Authors:
Wang Ruibing
;
Chang Yu
;
Meng Fancheng
;
Wang Chunming
;
Lu X.Y.
; et al.
Favorite
|
TC[WOS]:
31
TC[Scopus]:
35
|
Submit date:2018/11/07
Cephalotaxus
Cephalotaxine-type Alkaloids (Ctas)
Homoharringtonine
Bioactivity
Synthesis